Literature DB >> 29891058

Spastic ataxias.

Olena Bereznyakova1, Nicolas Dupré2.   

Abstract

The presence of spasticity and pyramidal features is a hallmark of some of hereditary ataxias, such as autosomal-recessive spastic ataxia of Charlevoix-Saguenay, other primary spastic ataxias, Friedreich ataxia, or ataxia with isolated vitamin E deficiency. Certain spastic paraplegias, such as spastic paraplegia 7, may present as an ataxic phenotype and often share common pathophysiologic pathways with cerebellar ataxias. Because of the rarity and genetic heterogeneity of these conditions, their molecular diagnosis remains challenging and time consuming. Herein we review the clinical, epidemiologic, and genetic features of the best-defined spastic ataxias with a focus on autosomal-recessive spastic ataxia of Charlevoix-Saguenay, one of the most frequent ataxias worldwide, which presents with a unique early-onset spastic ataxia phenotype. We briefly discuss other genetic and metabolic multisystem disorders where spastic ataxia is a secondary feature. Emphasis is placed on their typical age of onset and key clinical and imaging features that enable discrimination between these complex diseases.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  ARSACS; SPAX; autosomal-recessive spastic ataxia of Charlevoix–Saguenay; cerebellar ataxia; hereditary; pyramidal signs; spastic ataxia; spasticity

Mesh:

Year:  2018        PMID: 29891058     DOI: 10.1016/B978-0-444-64189-2.00012-3

Source DB:  PubMed          Journal:  Handb Clin Neurol        ISSN: 0072-9752


  6 in total

1.  Novel MAG Variant Causes Cerebellar Ataxia with Oculomotor Apraxia: Molecular Basis and Expanded Clinical Phenotype.

Authors:  Mariana Santos; Joana Damásio; Célia Kun-Rodrigues; Clara Barbot; Jorge Sequeiros; José Brás; Isabel Alonso; Rita Guerreiro
Journal:  J Clin Med       Date:  2020-04-23       Impact factor: 4.241

2.  Molecular and Cellular Substrates for the Friedreich Ataxia. Significance of Contactin Expression and of Antioxidant Administration.

Authors:  Antonella Bizzoca; Martina Caracciolo; Patrizia Corsi; Thea Magrone; Emilio Jirillo; Gianfranco Gennarini
Journal:  Molecules       Date:  2020-09-07       Impact factor: 4.411

3.  A Novel SPG7 Gene Pathogenic Variant in a Cypriot Family With Autosomal Recessive Spastic Ataxia.

Authors:  Christina Votsi; Antonis Ververis; Paschalis Nicolaou; Yiolanda-Panayiota Christou; Kyproula Christodoulou; Eleni Zamba-Papanicolaou
Journal:  Front Genet       Date:  2022-01-13       Impact factor: 4.599

4.  Whole-exome sequencing confirms implication of VPS13D as a potential cause of progressive spastic ataxia.

Authors:  Christelle M Durand; Chloé Angelini; Vincent Michaud; Claire Delleci; Isabelle Coupry; Cyril Goizet; Aurelien Trimouille
Journal:  BMC Neurol       Date:  2022-02-12       Impact factor: 2.474

5.  Analyzing Gene Expression Profiles from Ataxia and Spasticity Phenotypes to Reveal Spastic Ataxia Related Pathways.

Authors:  Andrea C Kakouri; Christina Votsi; Marios Tomazou; George Minadakis; Evangelos Karatzas; Kyproula Christodoulou; George M Spyrou
Journal:  Int J Mol Sci       Date:  2020-09-14       Impact factor: 5.923

6.  Molecular Characterization of Portuguese Patients with Hereditary Cerebellar Ataxia.

Authors:  Mariana Santos; Joana Damásio; Susana Carmona; João Luís Neto; Nadia Dehghani; Leonor Correia Guedes; Clara Barbot; José Barros; José Brás; Jorge Sequeiros; Rita Guerreiro
Journal:  Cells       Date:  2022-03-12       Impact factor: 6.600

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.